Abstract |
Pachymatismin is a new cytostatic factor extracted from the marine sponge Pachymatisma johnstonii Bowerbank 1842 (Demospongiae, Geodiidae), which has an antiproliferative effect in vitro on cells from a human non-small-cell bronchopulmonary carcinoma (NSCLC-N6). The substance, both administered as a continuous and discontinuous treatment, triggers the irreversible arrest of cells in the G0/G1 phase of the cell cycle and morphological changes, thereby causing their destruction. Taken all together, these observations suggest that pachymatismin would induce atypical terminal cellular differentiation.
|
Authors | M Zidane, P Pondaven, C Roussakis, M T More |
Journal | Anticancer research
(Anticancer Res)
1996 Sep-Oct
Vol. 16
Issue 5A
Pg. 2805-12
ISSN: 0250-7005 [Print] Greece |
PMID | 8917389
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Biological Factors
- Glycoproteins
- Intercellular Signaling Peptides and Proteins
- pachymatismin protein, Pachymatisma johnstonii
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Biological Factors
(pharmacology)
- Carcinoma, Non-Small-Cell Lung
(pathology)
- Cell Cycle
(drug effects, genetics)
- Drug Screening Assays, Antitumor
- Glycoproteins
(pharmacology)
- Humans
- Intercellular Signaling Peptides and Proteins
- Lung Neoplasms
(pathology)
- Porifera
(chemistry)
- Tumor Cells, Cultured
(drug effects, pathology)
|